Managers / Q3 2025 · view latest →
PAYDEN & RYGEL
CIK 0000919219 · 333 SOUTH GRAND, 40TH FL, LOS ANGELES, CA, 90071 · 213-830-4255
Summary
Payden & Rygel reported $1.2B in U.S.-listed holdings across 113 positions for Q3 2025.
Its largest position, QQQM, represents 5.0% of the portfolio.
Compared with Q2 2025, the fund opened 13 new positions and exited 13.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.6% · $1.0B
- ETP · 6.9% · $84M
- REIT · 3.7% · $45M
- MLP · 2.1% · $26M
- Other · 1.6% · $19M
- ADR · 0.0% · $129,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CVSCVS HEALTH CORP | NEW | +261.5K | 261.5K | +$20M | $20M |
| XLE US 11/21/25 P75 | NEW | +2.2K | 2.2K | +$19M | $19M |
| VLOVALERO ENERGY | NEW | +111.8K | 111.8K | +$19M | $19M |
| ADIANALOG DEVICES | NEW | +68.3K | 68.3K | +$17M | $17M |
| FITBFIFTH THIRD BANK | NEW | +243.6K | 243.6K | +$11M | $11M |
| LENLENNAR | NEW | +82.9K | 82.9K | +$10M | $10M |
| CMICUMMINS INC | NEW | +23.1K | 23.1K | +$10M | $10M |
| KIMKIMCO REALTY | NEW | +364.4K | 364.4K | +$8M | $8M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2025
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.3B | 114 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.4B | 115 | Feb 6, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.2B | 113 | Nov 10, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.2B | 113 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.2B | 125 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.2B | 124 | Feb 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.3B | 122 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.4B | 135 | Feb 13, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.4B | 131 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.7B | 122 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.9B | 136 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.7B | 136 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $1.7B | 138 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.0B | 128 | Apr 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.2B | 126 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.9B | 127 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $2.1B | 126 | Aug 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.2B | 120 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.0B | 133 | Feb 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.7B | 124 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.6B | 115 | Aug 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.4B | 115 | May 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.6B | 121 | Jan 31, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.5B | 118 | Oct 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.5B | 118 | Aug 6, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.4B | 119 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.